{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:48:22Z","timestamp":1794278902668,"version":"4.9.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971187, 82171401"],"award-info":[{"award-number":["81971187, 82171401"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801267"],"award-info":[{"award-number":["81801267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971183"],"award-info":[{"award-number":["81971183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["2018SHZDZX05"],"award-info":[{"award-number":["2018SHZDZX05"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diagnosis of essential tremor (ET) at an early stage can be difficult, especially when distinguishing it from healthy controls (HCs) and Parkinson\u2019s disease (PD). Recently, stool sample analysis of gut microbiota and its metabolites provides new ways to detect novel biomarkers for neurodegenerative diseases. Short-chain fatty acids (SCFAs), as the main metabolites of gut microbiota, were reduced in the feces of PD. However, fecal SCFAs in ET have never been investigated. We aimed to investigate the fecal SCFA levels in ET, assess their relationships with clinical symptoms and gut microbiota, and identify their potential diagnostic abilities. Fecal SCFAs and gut microbiota in 37 ET, 37 de novo PD and 35 HC were measured. Constipation, autonomic dysfunction and tremor severity were evaluated by scales. ET had lower fecal propionic, butyric and isobutyric acid levels than HC. Combined propionic, butyric and isobutyric acid distinguished ET from HC with an AUC of 0.751 (95% CI: 0.634\u20130.867). ET had lower fecal isovaleric and isobutyric acid levels than PD. Isovaleric and isobutyric acid differentiated ET from PD with an AUC of 0.743 (95% CI: 0.629\u20130.857). Fecal propionic acid was negatively correlated with constipation and autonomic dysfunction. Isobutyric and isovaleric acid were negatively associated with tremor severity. Lowered fecal SCFAs were related to a decreased abundance of <jats:italic>Faecalibacterium<\/jats:italic> and <jats:italic>Catenibacterium<\/jats:italic> in ET. In conclusion, fecal SCFAs were decreased in ET and correlated with clinical severity and gut microbiota changes. Fecal propionic, butyric, isobutyric and isovaleric acid might be potential diagnostic and differential diagnostic biomarkers for ET.<\/jats:p>","DOI":"10.1038\/s41531-023-00554-5","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T07:02:19Z","timestamp":1689577339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson\u2019s disease"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1593-1516","authenticated-orcid":false,"given":"Pei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6242-1025","authenticated-orcid":false,"given":"Shengdi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"554_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-021-00314-w","volume":"7","author":"T Welton","year":"2021","unstructured":"Welton, T. et al. Essential tremor. Nat. Rev. Dis. Primers 7, 83 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"554_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.parkreldis.2021.09.005","volume":"90","author":"S Pradeep","year":"2021","unstructured":"Pradeep, S. & Mehanna, R. Gastrointestinal disorders in hyperkinetic movement disorders and ataxia. Parkinsonism Relat. Disord. 90, 125\u2013133 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"554_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41582-019-0302-1","volume":"16","author":"ED Louis","year":"2020","unstructured":"Louis, E. D. & Faust, P. L. Essential tremor pathology: neurodegeneration and reorganization of neuronal connections. Nat. Rev. Neurol. 16, 69\u201383 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"554_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/bs.irn.2022.02.005","volume":"163","author":"A Gironell","year":"2022","unstructured":"Gironell, A. Is essential tremor a disorder of primary gaba dysfunction? Yes. Int. Rev. Neurobiol. 163, 259\u2013284 (2022).","journal-title":"Int. Rev. Neurobiol."},{"key":"554_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10571-021-01066-7","volume":"42","author":"N Dogra","year":"2022","unstructured":"Dogra, N., Mani, R. J. & Katare, D. P. The gut-brain axis: two ways signaling in Parkinson\u2019s disease. Cell Mol. Neurobiol. 42, 315\u2013332 (2022).","journal-title":"Cell Mol. Neurobiol."},{"key":"554_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-017-0802-6","volume":"17","author":"EMM Quigley","year":"2017","unstructured":"Quigley, E. M. M. Microbiota-brain-gut axis and neurodegenerative diseases. Curr. Neurol. Neurosci. Rep. 17, 94 (2017).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"554_CR7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/psyg.12583","volume":"20","author":"XJ Liu","year":"2020","unstructured":"Liu, X. J., Wu, L. H., Xie, W. R. & He, X. X. Faecal microbiota transplantation simultaneously ameliorated patient\u2019s essential tremor and irritable bowel syndrome. Psychogeriatrics 20, 796\u2013798 (2020).","journal-title":"Psychogeriatrics"},{"key":"554_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41531-022-00359-y","volume":"8","author":"P Zhang","year":"2022","unstructured":"Zhang, P. et al. Specific gut microbiota alterations in essential tremor and its difference from Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 98 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"554_CR9","doi-asserted-by":"publisher","first-page":"5613","DOI":"10.2147\/IDR.S342782","volume":"14","author":"S Luo","year":"2021","unstructured":"Luo, S., Zhu, H., Zhang, J. & Wan, D. The pivotal role of microbiota in modulating the neuronal-glial-epithelial unit. Infect Drug Resist. 14, 5613\u20135628 (2021).","journal-title":"Infect Drug Resist."},{"key":"554_CR10","doi-asserted-by":"publisher","unstructured":"Emmin, A. et al. Duodenal alpha-synuclein pathology and enteric gliosis in advanced Parkinson\u2019s disease. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.29358 (2023).","DOI":"10.1002\/mds.29358"},{"key":"554_CR11","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/mds.27380","volume":"33","author":"M Skorvanek","year":"2018","unstructured":"Skorvanek, M. et al. \u03b1-Synuclein antibody 5G4 identifies manifest and prodromal Parkinson\u2019s disease in colonic mucosa. Mov. Disord. 33, 1366\u20131368 (2018).","journal-title":"Mov. Disord."},{"key":"554_CR12","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.parkreldis.2017.07.006","volume":"46","author":"M Algarni","year":"2018","unstructured":"Algarni, M. & Fasano, A. The overlap between essential tremor and Parkinson disease. Parkinsonism Relat. Disord. 46, S101\u2013S104 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"554_CR13","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480.e1412 (2016).","journal-title":"Cell"},{"key":"554_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger, M. M. et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Parkinsonism Relat. Disord. 32, 66\u201372 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"554_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4049\/jimmunol.1601247","volume":"198","author":"E Blacher","year":"2017","unstructured":"Blacher, E., Levy, M., Tatirovsky, E. & Elinav, E. Microbiome-modulated metabolites at the interface of host immunity. J. Immunol. 198, 572\u2013580 (2017).","journal-title":"J. Immunol."},{"key":"554_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile, B., Van Oudenhove, L., Vervliet, B. & Verbeke, K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat. Rev. Gastroenterol. Hepatol. 16, 461\u2013478 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"554_CR17","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen, S. J. et al. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 98, e848\u2013e858 (2022).","journal-title":"Neurology"},{"key":"554_CR18","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G den Besten","year":"2013","unstructured":"den Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325\u20132340 (2013).","journal-title":"J. Lipid Res."},{"key":"554_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1017\/S0029665120006916","volume":"80","author":"C Martin-Gallausiaux","year":"2021","unstructured":"Martin-Gallausiaux, C., Marinelli, L., Blotti\u00e8re, H. M., Larraufie, P. & Lapaque, N. Scfa: Mechanisms and functional importance in the gut. Proc. Nutr. Soc. 80, 37\u201349 (2021).","journal-title":"Proc. Nutr. Soc."},{"key":"554_CR20","doi-asserted-by":"publisher","first-page":"16767","DOI":"10.1073\/pnas.0808567105","volume":"105","author":"BS Samuel","year":"2008","unstructured":"Samuel, B. S. et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding g protein-coupled receptor, gpr41. Proc. Natl Acad. Sci. USA 105, 16767\u201316772 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"554_CR21","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","volume":"48","author":"DR Donohoe","year":"2012","unstructured":"Donohoe, D. R. et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol. Cell 48, 612\u2013626 (2012).","journal-title":"Mol. Cell"},{"key":"554_CR22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1101\/gr.5540007","volume":"17","author":"A Rada-Iglesias","year":"2007","unstructured":"Rada-Iglesias, A. et al. Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes. Genome Res. 17, 708\u2013719 (2007).","journal-title":"Genome Res."},{"key":"554_CR23","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","volume":"15","author":"E Kontopoulos","year":"2006","unstructured":"Kontopoulos, E., Parvin, J. D. & Feany, M. B. Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum. Mol. Genet. 15, 3012\u20133023 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"554_CR24","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","volume":"32","author":"DM Chuang","year":"2009","unstructured":"Chuang, D. M., Leng, Y., Marinova, Z., Kim, H. J. & Chiu, C. T. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 32, 591\u2013601 (2009).","journal-title":"Trends Neurosci."},{"key":"554_CR25","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","volume":"26","author":"I Paiva","year":"2017","unstructured":"Paiva, I. et al. Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage. Hum. Mol. Genet. 26, 2231\u20132246 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"554_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.brainres.2010.07.041","volume":"1354","author":"SK Kidd","year":"2010","unstructured":"Kidd, S. K. & Schneider, J. S. Protection of dopaminergic cells from mpp+-mediated toxicity by histone deacetylase inhibition. Brain Res. 1354, 172\u2013178 (2010).","journal-title":"Brain Res."},{"key":"554_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","volume":"246","author":"R St Laurent","year":"2013","unstructured":"St Laurent, R., O'Brien, L. M. & Ahmad, S. T. Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced drosophila model of Parkinson\u2019s disease. Neuroscience 246, 382\u2013390 (2013).","journal-title":"Neuroscience"},{"key":"554_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0439-y","volume":"6","author":"L Hoyles","year":"2018","unstructured":"Hoyles, L. et al. Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier. Microbiome 6, 55 (2018).","journal-title":"Microbiome"},{"key":"554_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451\u2013455 (2013).","journal-title":"Nature"},{"key":"554_CR30","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3390\/molecules25112502","volume":"25","author":"F Ostendorf","year":"2020","unstructured":"Ostendorf, F., Metzdorf, J., Gold, R., Haghikia, A. & T\u00f6nges, L. Propionic acid and fasudil as treatment against rotenone toxicity in an in vitro model of Parkinson\u2019s disease. Molecules 25, 2502 (2020).","journal-title":"Molecules"},{"key":"554_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00988-6","volume":"9","author":"YF Hou","year":"2021","unstructured":"Hou, Y. F. et al. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson\u2019s disease. Microbiome 9, 34 (2021).","journal-title":"Microbiome"},{"key":"554_CR32","doi-asserted-by":"publisher","first-page":"104158","DOI":"10.1016\/j.isci.2022.104158","volume":"25","author":"TD Horvath","year":"2022","unstructured":"Horvath, T. D. et al. Bacteroides ovatus colonization influences the abundance of intestinal short chain fatty acids and neurotransmitters. iScience 25, 104158 (2022).","journal-title":"iScience"},{"key":"554_CR33","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1093\/brain\/awu314","volume":"137","author":"ED Louis","year":"2014","unstructured":"Louis, E. D. et al. Reduced Purkinje cell dendritic arborization and loss of dendritic spines in essential tremor. Brain 137, 3142\u20133148 (2014).","journal-title":"Brain"},{"key":"554_CR34","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1053\/j.gastro.2010.01.053","volume":"138","author":"R Soret","year":"2010","unstructured":"Soret, R. et al. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology 138, 1772\u20131782 (2010).","journal-title":"Gastroenterology"},{"key":"554_CR35","doi-asserted-by":"publisher","first-page":"9349","DOI":"10.1111\/jcmm.15586","volume":"24","author":"Q He","year":"2020","unstructured":"He, Q. et al. Astragaloside iv alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation. J. Cell Mol. Med. 24, 9349\u20139361 (2020).","journal-title":"J. Cell Mol. Med."},{"key":"554_CR36","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731\u201316736 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"554_CR37","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1099\/00207713-50-4-1595","volume":"50","author":"A Kageyama","year":"2000","unstructured":"Kageyama, A. & Benno, Y. Catenibacterium mitsuokai gen. Nov., sp. Nov., a Gram-positive anaerobic bacterium isolated from human faeces. Int. J. Syst. Evol. Microbiol. 50, 1595\u20131599 (2000).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"554_CR38","doi-asserted-by":"publisher","first-page":"947367","DOI":"10.3389\/fnut.2022.947367","volume":"9","author":"Y Ma","year":"2022","unstructured":"Ma, Y., Fei, Y., Han, X., Liu, G. & Fang, J. Lactobacillus plantarum alleviates obesity by altering the composition of the gut microbiota in high-fat diet-fed mice. Front. Nutr. 9, 947367 (2022).","journal-title":"Front. Nutr."},{"key":"554_CR39","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.3389\/fmicb.2018.01991","volume":"9","author":"GA Hedblom","year":"2018","unstructured":"Hedblom, G. A., Reiland, H. A., Sylte, M. J., Johnson, T. J. & Baumler, D. J. Segmented filamentous bacteria\u2014metabolism meets immunity. Front. Microbiol. 9, 1991 (2018).","journal-title":"Front. Microbiol."},{"key":"554_CR40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov, I. I. et al. Induction of intestinal th17 cells by segmented filamentous bacteria. Cell 139, 485\u2013498 (2009).","journal-title":"Cell"},{"key":"554_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3390\/microorganisms8040573","volume":"8","author":"M Vacca","year":"2020","unstructured":"Vacca, M. et al. The controversial role of human gut Lachnospiraceae. Microorganisms 8, 573 (2020).","journal-title":"Microorganisms"},{"key":"554_CR42","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mds.27121","volume":"33","author":"KP Bhatia","year":"2018","unstructured":"Bhatia, K. P. et al. Consensus statement on the classification of tremors. From the task force on tremor of the International Parkinson and Movement Disorder Society. Mov. Disord. 33, 75\u201387 (2018).","journal-title":"Mov. Disord."},{"key":"554_CR43","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. Mds clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"554_CR44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/mds.26522","volume":"31","author":"P Martinez-Martin","year":"2016","unstructured":"Martinez-Martin, P. et al. Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson\u2019s disease. Mov. Disord. 31, 270\u2013279 (2016).","journal-title":"Mov. Disord."},{"key":"554_CR45","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/mds.21333","volume":"22","author":"A Schrag","year":"2007","unstructured":"Schrag, A. et al. Depression rating scales in Parkinson\u2019s disease: critique and recommendations. Mov. Disord. 22, 1077\u20131092 (2007).","journal-title":"Mov. Disord."},{"key":"554_CR46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/BF02056950","volume":"39","author":"F Agachan","year":"1996","unstructured":"Agachan, F., Chen, T., Pfeifer, J., Reissman, P. & Wexner, S. D. A constipation scoring system to simplify evaluation and management of constipated patients. Dis. Colon Rectum 39, 681\u2013685 (1996).","journal-title":"Dis. Colon Rectum"},{"key":"554_CR47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/apt.13746","volume":"44","author":"MR Blake","year":"2016","unstructured":"Blake, M. R., Raker, J. M. & Whelan, K. Validity and reliability of the bristol stool form scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 44, 693\u2013703 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"554_CR48","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/mds.27233","volume":"33","author":"M Skorvanek","year":"2018","unstructured":"Skorvanek, M. et al. Global scales for cognitive screening in Parkinson\u2019s disease: critique and recommendations. Mov. Disord. 33, 208\u2013218 (2018).","journal-title":"Mov. Disord."},{"key":"554_CR49","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser, M., Marinus, J., Stiggelbout, A. M. & Van Hilten, J. J. Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT. Mov. Disord. 19, 1306\u20131312 (2004).","journal-title":"Mov. Disord."},{"key":"554_CR50","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/mds.25162","volume":"27","author":"R Elble","year":"2012","unstructured":"Elble, R. et al. Reliability of a new scale for essential tremor. Mov. Disord. 27, 1567\u20131569 (2012).","journal-title":"Mov. Disord."},{"key":"554_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.21198","volume":"22","author":"CG Goetz","year":"2007","unstructured":"Goetz, C. G. et al. Movement disorder society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov. Disord. 22, 41\u201347 (2007).","journal-title":"Mov. Disord."},{"key":"554_CR52","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz, C. G. et al. Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov. Disord. 19, 1020\u20131028 (2004).","journal-title":"Mov. Disord."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00554-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00554-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00554-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T07:02:24Z","timestamp":1689577344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00554-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00554-5","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"assertion":[{"value":"25 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"115"}}